If you’ve recently gone shopping for a new pair of eyeglasses there’s a chance you may have come across some blue-light-blocking glasses, which seem to be everywhere, from online to brick-and-mortar optical stores. Blue-light block glasses are the newest trend and Dr. Sunir Garg discusses if these glasses are actually beneficial to helping reduce eye strain... read more
The 71st Annual Wills Eye Conference continues today with two Retina presentations from our physicians. Dr. Jason Hsu presented Are Your Patients Returning? Loss to Follow-Up After Intravitreal Injections and Its Impact on Patient Outcomes and Dr. Sonia Mehta presented, Updates in the Management of AMD and DME 2019. The moderator for the Retina Panel was Dr.... read more
Wills Eye Hospital is holding their 71st Annual Wills Eye Conference this weekend, March 7-9, 2019. Mid Atlantic Retina, the retina physicians of Wills Eye, will be attending and presenting on several topics. Dr. Sunir Garg, while serving as the Wills Eye Conference Chairman, is presenting research on the Comfort and Efficacy of Povidone Iodine 5%... read more
“I felt very comfortable at Mid Atlantic Retina’s Newtown Square office. I was pleased that my wait wasn’t long. All of the staff was friendly from the front desk through my whole experience. And Dr. Garg was very reassuring and easy to talk with!” - Dale L.
Researchers have completed the first gene therapy procedure aimed at stoping age-related macular degeneration. Dr. Allen Ho commented, “What’s unique about this particular clinical trial is that they are trying gene therapy surgically delivered to the sub retinal space to try to modify the disease process of dry macular degeneration." Read the full article from... read more
Diabetic retinopathy is the most common cause of vision loss among people with diabetes and is the most frequent cause of new cases of blindness among adults ages 20 to 74. Dr. Omesh Gupta discusses how treatments have radically improved in the recent years. Read the full article here from AARP.
"Dr. Regillo cared for my dad at Mid Atlantic Retina’s Newtown Square office, and we very much appreciate his attention to my dad's well being - no one looks forward to a “shot in the eye ball”, but his administering of Dad’s care was superb. Upon seeing the article from The Inquirer, I reminded my... read more
Association of Intravitreal Anti–Vascular Endothelial Growth Factor Therapy With Risk of Stroke, Myocardial Infarction, and Death in Patients With Exudative Age-Related Macular Degeneration
A study recently done out of the Mayo Clinic, looked into the risk of strokes due to anti-VEGF therapy for AMD. The study has found that there is no association between the two, and the use of anti-VEGF therapy is still the best option for patients with AMD. Dr. Carl Regillo added his own comment... read more
Dr. Allen Ho and Dr. Carl Regillo attended the annual Hawaiian Eye & Retina Meeting from January 20-25 and presented on a number of topics. Dr. Ho spoke about “New RPE cell-based treatments in development for dry AMD”, and you can watch the video here from Healio. Dr. Regillo presented on... read more
Dr. Sunir Garg, co-author of a study looking into how statins can help prevent diabetic retinopathy, says, “Statins may actually help patients’ eyeballs as well, not just their hearts.” Read more on this study about how people with diabetes could benefit from using statins to delay the risk of diabetic retinopathy.